To the Editor: Chronic graft-versus-host disease (cGVHD) remains a major cause of morbidity following allogeneic hematopoietic stem cell transplantation, yet therapeutic evidence in pediatric patients is limited and largely extrapolated from adult studies. This setting differs substantially from adults, underscoring a persistent evidence gap in pediatric-specific management strategies.
Liyan Fan
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Liyan
Contact Liyan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack